[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350085-105":59,"doc-detail-350085-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","dual-mechanism-of-phytochemicals-in-cancer-therapy-synergistic-anti-angiogenic-potency-in-cancer-and-proangiogenic-impact-against-chemotherapy-induced-cytotoxicity-in-vital-organs","Dual-mechanism of phytochemicals in cancer therapy - synergistic anti-angiogenic potency in cancer and proangiogenic impact against chemotherapy-induced cytotoxicity in vital organs","","Angiogenesis drives tumor growth and metastasis, but physiological angiogenesis is also vital for tissue repair and endothelial homeostasis, creating a therapeutic dilemma when cytotoxic chemotherapy compromises vascular integrity. This review synthesizes pro- and anti-angiogenic pathways governing tumor vascularization and evaluates limits of current anti-angiogenic strategies, including resistance and delivery barriers. It highlights evidence that selected phytochemicals modulate angiogenesis in a context-dependent manner, inhibiting pathological tumor angiogenesis while supporting endothelial defense and microvascular recovery via antioxidant, anti-inflammatory, and anti-apoptotic signaling. Translational needs including bioavailability, standardization, dosing windows, safety, and biomarker-led clinical trials are discussed.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dual-mechanism-of-phytochemicals-in-cancer-therapy-synergistic-anti-angiogenic-potency-in-cancer-and-proangiogenic-impact-against-chemotherapy-induced-cytotoxicity-in-vital-organs/350085/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dual-mechanism-of-phytochemicals-in-cancer-therapy-synergistic-anti-angiogenic-potency-in-cancer-and-proangiogenic-impact-against-chemotherapy-induced-cytotoxicity-in-vital-organs/350085.png","ImageObject",300,407,{"name":92,"@type":93},"WPS_1786070896","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"Why is angiogenesis a challenge in cancer therapy?","Question",{"text":112,"@type":113},"Tumor angiogenesis supports growth and metastasis, while physiological angiogenesis is necessary for tissue repair and endothelial homeostasis. Suppressing tumor vessels can therefore risk impairing vascular integrity, especially during cytotoxic chemotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the review cover regarding anti-angiogenic therapy?",{"text":117,"@type":113},"It summarizes key pro- and anti-angiogenic pathways regulating tumor vascularization, and highlights limitations of current anti-angiogenic therapies such as resistance and delivery barriers.",{"name":119,"@type":110,"acceptedAnswer":120},"How do selected phytochemicals influence angiogenesis according to the review?",{"text":121,"@type":113},"The review reports context-dependent modulation: many phytochemicals inhibit pathological tumor angiogenesis through signaling networks such as VEGF/HIF-1α/NF-κB/MMP-related pathways, while promoting endothelial defense and microvascular recovery in non-cancerous tissues through antioxidant, anti-inflammatory, and anti-apoptotic routes (e.g., Nrf2/HO-1).",{"name":123,"@type":110,"acceptedAnswer":124},"What translational requirements are discussed for future clinical use?",{"text":125,"@type":113},"Bioavailability, standardization, dosing windows, safety, and the need for future biomarker-driven clinical trials are emphasized to support rational adjunct development.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},350085,1790916352,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","OPEN ACCESS  \nEDITED BY  \nMohammed Abu El-Magd, Kafrelsheikh University, Egypt  \nREVIEWED BY  \nPengxiang Min,  \nUppsala University, Sweden Riccardo Tornese, University of Salento, Italy  \n*CORRESPONDENCE  \nHazim O. Khalifa,  \n [hazimkhalifa@uaeu.ac.ae](hazimkhalifa@uaeu.ac.ae)  \nRECEIVED 08 January 2026  \nREVISED 17 February 2026  \nACCEPTED 19 February 2026  \nPUBLISHED 23 March 2026  \nCITATION  \nElsayed Abouzed DE, Bayoumy NMK, Hagar H, Rabea SM, Hashem H and Khalifa HO (2026) Dual-mechanism of phytochemicals in cancer therapy:  \nsynergistic anti-angiogenic potency in cancer and proangiogenic impact against chemotherapy-induced cytotoxicity in vital organs.  \nFront. Pharmacol. 17:1783390 .  \ndoi: 10.3389/fphar.2026.1783390  \nCOPYRIGHT  \n© 2026 Elsayed Abouzed, Bayoumy, Hagar, Rabea, Hashem and Khalifa. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTYPE Review  \nPUBLISHED 23 March 2026  \nDOI 10.3389/fphar.2026.1783390  \nDual-mechanism of phytochemicals in cancer therapy: synergistic  \nanti-angiogenic potency in cancer and proangiogenic impact against chemotherapy-induced cytotoxicity in vital organs  \nDeiaa E. Elsayed Abouzed 1, Nervana M. K. Bayoumy 2, Hanan Hagar 3,4, Safwat M. Rabea 5, Hamada Hashem 6 and Hazim O. Khalifa 7*  \n1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Sohag University, Sohag, Egypt, 2Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia, 3Department of Biology, University of Arkansas at Little Rock, Little Rock, AR, United States, 4Department of Pharmacology, College of Pharmacy, Zagazig University, Zagazig, Egypt, 5Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt, 6Pharmaceutical Chemistry Department, Faculty of Pharmacy, Sohag University, Sohag, Egypt, 7Department of Veterinary Medicine, College of Agriculture and Veterinary Medicine, United Arab Emirates University, Al Ain, United Arab Emirates  \nAngiogenesis is essential for tumor growth and metastasis, yet physiological angiogenesis is equally critical for tissue repair and endothelial homeostasis. This creates a therapeutic dilemma: suppressing tumor neovascularization without impairing vascular integrity in healthy organs, particularly under cytotoxic chemotherapy. This review summarizes key pro- and antiangiogenic pathways that regulate tumor vascularization, highlights limitations of current anti-angiogenic therapies (including resistance and delivery barriers), and synthesizes evidence that selected phytochemicals exert context-dependent angiogenesis modulation. Specifically, many compounds inhibit pathological tumor angiogenesis (via VEGF/HIF-1α/NF-κB/MMP-related signaling) while supporting endothelial defense and microvascular recovery in non-cancerous tissues through antioxidant, anti-inflammatory, and anti-apoptotic pathways (e.g., Nrf2/HO-1) . Finally, we discuss translational requirements—bioavailability, standardization, dosing windows, and safety—to inform rational adjunct development and future biomarker-driven clinical trials.  \nKEYWORDS  \nangiogenesis, antiangiogenetic therapy, chemotherapy toxicity, cytoprotection, phytochemicals  \n1 Introduction  \nCancer is the primary cause of morbidity and death globally, and its progression is intriguingly associated with hemodynamics (Santucci et al., 2020; Torre et al., 2016) . After a certain size, tumors need a steady flow of oxygen and nutrients to develop and spread. Tumor angiogenesis, a process that creates new blood vessels to meet this need, is controlled by a careful balancing act between pro-and an","cbCaibuQyEazLxsR","https://ap.wps.com/l/cbCaibuQyEazLxsR","pdf",4489708,18,"English","# Introduction\n## Angiogenesis and the angiogenic switch in cancer\n## Pro- and anti-angiogenic mediators\n## Tumor control mechanisms and lymphatic vessel targeting\n# Review Scope and Translational Considerations","[{\"question\":\"Why is angiogenesis a challenge in cancer therapy?\",\"answer\":\"Tumor angiogenesis supports growth and metastasis, while physiological angiogenesis is necessary for tissue repair and endothelial homeostasis. Suppressing tumor vessels can therefore risk impairing vascular integrity, especially during cytotoxic chemotherapy.\"},{\"question\":\"What does the review cover regarding anti-angiogenic therapy?\",\"answer\":\"It summarizes key pro- and anti-angiogenic pathways regulating tumor vascularization, and highlights limitations of current anti-angiogenic therapies such as resistance and delivery barriers.\"},{\"question\":\"How do selected phytochemicals influence angiogenesis according to the review?\",\"answer\":\"The review reports context-dependent modulation: many phytochemicals inhibit pathological tumor angiogenesis through signaling networks such as VEGF/HIF-1α/NF-κB/MMP-related pathways, while promoting endothelial defense and microvascular recovery in non-cancerous tissues through antioxidant, anti-inflammatory, and anti-apoptotic routes (e.g., Nrf2/HO-1).\"},{\"question\":\"What translational requirements are discussed for future clinical use?\",\"answer\":\"Bioavailability, standardization, dosing windows, safety, and the need for future biomarker-driven clinical trials are emphasized to support rational adjunct development.\"}]","Dual-mechanism of phytochemicals in cancer therapy - synergistic anti-angiogenic potency in cancer and proangiogenic impact against chemotherapy-induced cytotoxicity in vital organs | PDF",1790087083,45,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62bd6fdb813709b44db05cab0fa93cc1.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/816a57a78f5124049f5110851dead468.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4c97cae972a3f548697b8268fae6b1d.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11c4aec8f40938e28872ce4b8290aeed.webp",980,1385]